MedPath

Protein synthesis rates in muscle tissue in vivo in patients with mitochondrial myopathy after high intensity interval exercise training

Conditions
metabolic diseases
metabolic myopathy
10028302
Registration Number
NL-OMON51490
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
16
Inclusion Criteria

- Age >= 18 years
- m.3243A>G point mutation or single, large scale mtDNA deletion

Exclusion Criteria

* insufficient mastery of the Dutch language
* pregnancy
* severe cardiopulmonary disease (chest pain, heart failure, arrhythmia,
pacemaker, cardiac surgery, severe exertional dyspnea, emphysema). If cardiac
involvement is present, inclusion will be evaluated by one of the cardiologists
with expertise in mitochondrial cardiomyopathy.
* coagulopathy (anti-platelet therapy is allowed)
* cognitive dysfunction
* not able to perform the high intensity training protocol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary study parameters include mitochondrial and myofibrillar protein<br /><br>synthesis rates of vastus lateralis muscle, calculated from the increase in<br /><br>enriched deuterized alanine in muscle tissue. The trained muscle will be<br /><br>compared with the untrained muscle after 14 days of aerobic exercise.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary study parameters are muscle tissue amino acid composition and<br /><br>nitrogen content. Also mitochondrial respiration of muscle tissue from the<br /><br>trained and untrained leg will be compared to baseline tissue using the<br /><br>Oroboros technique. </p><br>
© Copyright 2025. All Rights Reserved by MedPath